Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression - PubMed (original) (raw)
Melatonin prevents human pancreatic carcinoma cell PANC-1-induced human umbilical vein endothelial cell proliferation and migration by inhibiting vascular endothelial growth factor expression
Peilin Cui et al. J Pineal Res. 2012 Mar.
Abstract
Melatonin is an important natural oncostatic agent, and our previous studies have found its inhibitory action on tumor angiogenesis, but the mechanism remains unclear. It is well known that vascular endothelial growth factor (VEGF) plays key roles in tumor angiogenesis and has become an important target for antitumor therapy. Pancreatic cancer is a representative of the most highly vascularized and angiogenic solid tumors, which responds poorly to chemotherapy and radiation. Thus, seeking new treatment strategies targeting which have anti-angiogenic capability is urgent in clinical practice. In this study, a co-culture system between human umbilical vein endothelial cells (HUVECs) and pancreatic carcinoma cells (PANC-1) was used to investigate the direct effect of melatonin on the tumor angiogenesis and its possible action on VEGF expression. We found HUVECs exhibited an increased cell proliferation and cell migration when co-cultured with PANC-1 cells, but the process was prevented when melatonin added to the incubation medium. Melatonin at concentrations of 1 μm and 1 mm inhibited the cell proliferation and migration of HUVECs and also decreased both the VEGF protein secreted to the cultured medium and the protein produced by the PANC-1 cells. In addition, the VEGF mRNA expression was also down-regulated by melatonin. Taken together, our present study shows that melatonin at pharmacological concentrations inhibited the elevated cell proliferation and cell migration of HUVECs stimulated by co-culturing them with PANC-1 cells; this was associated with a suppression of VEGF expression in PANC-1 cells.
© 2011 John Wiley & Sons A/S.
Similar articles
- Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors.
Li M, Yang H, Chai H, Fisher WE, Wang X, Brunicardi FC, Yao Q, Chen C. Li M, et al. Cancer. 2004 Nov 15;101(10):2341-50. doi: 10.1002/cncr.20634. Cancer. 2004. PMID: 15476280 - Antiangiogenic effects of melatonin in endothelial cell cultures.
Alvarez-García V, González A, Alonso-González C, Martínez-Campa C, Cos S. Alvarez-García V, et al. Microvasc Res. 2013 May;87:25-33. doi: 10.1016/j.mvr.2013.02.008. Epub 2013 Mar 6. Microvasc Res. 2013. PMID: 23473980 - Targeting the vascular endothelial growth factor in hematologic malignancies.
Paesler J, Gehrke I, Poll-Wolbeck SJ, Kreuzer KA. Paesler J, et al. Eur J Haematol. 2012 Nov;89(5):373-84. doi: 10.1111/ejh.12009. Epub 2012 Sep 20. Eur J Haematol. 2012. PMID: 22928557 Review. - Melatonin influences pancreatic cancerogenesis.
Jaworek J, Leja-Szpak A. Jaworek J, et al. Histol Histopathol. 2014 Apr;29(4):423-31. doi: 10.14670/HH-29.10.423. Epub 2013 Nov 21. Histol Histopathol. 2014. PMID: 24258787 Review.
Cited by
- Usefulness of melatonin as complementary to chemotherapeutic agents at different stages of the angiogenic process.
González-González A, González A, Rueda N, Alonso-González C, Menéndez JM, Martínez-Campa C, Mitola S, Cos S. González-González A, et al. Sci Rep. 2020 Mar 16;10(1):4790. doi: 10.1038/s41598-020-61622-x. Sci Rep. 2020. PMID: 32179814 Free PMC article. - Melatonin down-regulates volume-sensitive chloride channels in fibroblasts.
Ben Soussia I, Mies F, Naeije R, Shlyonsky V. Ben Soussia I, et al. Pflugers Arch. 2012 Sep;464(3):273-85. doi: 10.1007/s00424-012-1139-2. Epub 2012 Jul 27. Pflugers Arch. 2012. PMID: 22837012 - Roles of some antioxidants in modulation of cardiac myopathy induced by sodium nitrite via down-regulation of mRNA expression of NF-κB, Bax, and flt-1 and suppressing DNA damage.
Fadda LM, Attia HA, Al-Rasheed NM, Ali HM, Al-Rasheed NM. Fadda LM, et al. Saudi Pharm J. 2018 Feb;26(2):217-223. doi: 10.1016/j.jsps.2017.12.008. Epub 2017 Dec 11. Saudi Pharm J. 2018. PMID: 30166919 Free PMC article. - Inhibition of VEGF-Induced VEGFR-2 Activation and HUVEC Migration by Melatonin and Other Bioactive Indolic Compounds.
Cerezo AB, Hornedo-Ortega R, Álvarez-Fernández MA, Troncoso AM, García-Parrilla MC. Cerezo AB, et al. Nutrients. 2017 Mar 8;9(3):249. doi: 10.3390/nu9030249. Nutrients. 2017. PMID: 28282869 Free PMC article. - Effect of Melatonin in Epithelial Mesenchymal Transition Markers and Invasive Properties of Breast Cancer Stem Cells of Canine and Human Cell Lines.
Gonçalves Ndo N, Colombo J, Lopes JR, Gelaleti GB, Moschetta MG, Sonehara NM, Hellmén E, Zanon Cde F, Oliani SM, Zuccari DA. Gonçalves Ndo N, et al. PLoS One. 2016 Mar 2;11(3):e0150407. doi: 10.1371/journal.pone.0150407. eCollection 2016. PLoS One. 2016. PMID: 26934679 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical